日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy

心血管处方医师对药物基因组学的态度:ESC心血管药物治疗工作组的一项调查

Magavern, Emma F; Dan, G-Andrei; Savarese, Gianluigi; Borghi, Claudio; Dobrev, Dobramir; Tamargo, Juan; Ferdinandy, Peter; McDermott, John H; Newman, William G; Pirmohamed, Munir; Caulfield, Mark J; Kaski, Juan Carlos

Critical medications in cardiology: strategic policy of the European Medicines Agency

心脏病学中的关键药物:欧洲药品管理局的战略政策

Dobrev, Dobromir; Tamargo, Juan; Szymański, Piotr

News in cardiovascular pharmacotherapy from the ACC.25 Meeting

来自 ACC.25 会议的心血管药物治疗新闻

Delpón, Eva; Caballero, Ricardo; Tamargo, Juan

Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus

合并症患者血脂异常的管理:应对挑战:2型糖尿病

Drexel, Heinz; Festa, Andreas; Schmidt, Thomas A; Rocca, Bianca; Dobrev, Dobromir; Agewall, Stefan; Tamargo, Juan; Kaser, Susanne

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024

2024 年的新型药物和新型心血管药物治疗策略

Tamargo, Juan; Agewall, Stefan; Ambrosio, Giuseppe; Borghi, Claudio; Cerbai, Elisabetta; Dan, Gheorghe A; Drexel, Heinz; Ferdinandy, Péter; Grove, Erik Lerkevang; Klingenberg, Roland; Morais, Joao; Parker, William; Rocca, Bianca; Sulzgruber, Patrick; Semb, Anne Grete; Sossalla, Samuel; Kaski, Juan Carlos; Dobrev, Dobromir

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

抗心律失常药物实用汇编:欧洲心脏病学会欧洲心律协会临床共识声明

Merino, Jose L; Tamargo, Juan; Blomström-Lundqvist, Carina; Boriani, Giuseppe; Crijns, Harry J G M; Dobrev, Dobromir; Goette, Andreas; Hohnloser, Stefan H; Naccarelli, Gerald V; Reiffel, James A; Tfelt-Hansen, Jacob; Martínez-Cossiani, Marcel; Camm, A John; Almendral Garrote, Jesus M; Średniawa, Beata; Kułakowski, Piotr; Savelieva, Irina; Potpara, Tatjana; Gorenek, Bulent; Zamorano, Jose L

Sex-related differences in cardiovascular pharmacotherapy: fiction or fact? Why can't we see the evidence?

心血管药物治疗中的性别差异:是虚构还是事实?为什么我们看不到证据?

Tamargo, Juan; Delpón, Eva

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

欧洲心力衰竭杂志共识声明。射血分数降低合并房颤的心力衰竭患者的药物治疗:证据回顾与行动呼吁

Luedde, Mark; Agewall, Stefan; Ambrosio, Giuseppe; Bayes-Genis, Antoni; Borghi, Claudio; Cerbai, Elisabetta; Dan, Gheorghe A; Drexel, Heinz; Ferdinandy, Péter; Grove, Erik Lerkevang; Kaski, Juan Carlos; Klingenberg, Roland; Morais, Joao; Parker, William; Petrie, Mark C; Rocca, Bianca; Semb, Anne Grete; Senni, Michele; Sohns, Christian; Sulzgruber, Patrick; Tamargo, Juan; Metra, Marco; Böhm, Michael; Dobrev, Dobromir; Sossalla, Samuel

Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems

回复 Benndorff 和 DiFrancesco:在表达系统中利用细胞贴附配置进行可靠的人类 HCN4 单通道记录

Cámara-Checa, Anabel; Rubio-Alarcón, Marcos; Dago, María; Crespo-García, Teresa; Rapún, Josu; Marín, María; Tamargo, Juan; Gómez, Ricardo; Caballero, Ricardo; Delpón, Eva

Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects

聚焦2024年ESC/EACTS房颤管理指南:10个新的关键方面

Rienstra, Michiel; Tzeis, Stylianos; Bunting, Karina V; Caso, Valeria; Crijns, Harry J G M; De Potter, Tom J R; Sanders, Prashanthan; Svennberg, Emma; Casado-Arroyo, Ruben; Dwight, Jeremy; Guasti, Luigina; Hanke, Thorsten; Jaarsma, Tiny; Lettino, Maddalena; Løchen, Maja-Lisa; Lumbers, R Thomas; Maesen, Bart; Mølgaard, Inge; Rosano, Giuseppe M C; Schnabel, Renate B; Suwalski, Piotr; Tamargo, Juan; Tica, Otilia; Traykov, Vassil; Kotecha, Dipak; Van Gelder, Isabelle C